Gyre Therapeutics Inc share price logo

Gyre Therapeutics Inc Share Price

NASDAQ: GYRE

Small Cap

$7.55

-0.04

(-0.53%)

as on

Gyre Therapeutics Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $7.52
    $7.85
    downward going graph

    0.40%

    Downside

    3.97%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $6.11
    $19
    downward going graph

    19.07%

    Downside

    151.66%

    Upside

    downward going graph

Gyre Therapeutics Inc share price movements today

Previous Close
$7.59
Open
$7.59
Volume
175.1K
Day's Low - High
$7.52 - $7.85
52 Week Low - High
$6.11 - $19

Gyre Therapeutics Inc Historical Returns

1 Month Return
-6.76 %
3 Month Return
-6.18 %
1 Year Return
-45.94 %
3 Year Return
0 %
5 Year Return
0 %

Gyre Therapeutics Inc Stock Fundamentals & Key Indicators

Check Gyre Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$717.5M

EPS (TTM)

0.13

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.63%

PE Ratio (TTM)

395

Industry PE ratio

0

P/B Ratio

395

PEG Ratio

0

EBITDA

11.5M

Revenue (TTM)

102.2M

Profit Margin

4.08%

Return On Equity TTM

7.84%

Gyre Therapeutics Inc Stock Valuation

Track how Gyre Therapeutics Inc P/E has moved over time to understand its valuation trends.

Gyre Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (164.25x)

September 30, 2024

Industry (0.00x)

September 17, 2025

Today (395.00x)

September 17, 2025

Highest (165.42x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 395.00x

Gyre Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Gyre Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
SELL$717.5MNA3954.08%
BUY$60.5B252.04%-505.15-12.96%
NA$39.0BNANA-3.89%
BUY$100.3B44.17%27.8531.86%
BUY$59.6B1.78%14.131.37%

Stock Returns calculator for Gyre Therapeutics Inc Stock including INR - Dollar returns

The Gyre Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

Gyre Therapeutics Inc investment value today

Current value as on today

₹58,373

Returns

₹41,627

(-41.63%)

Returns from Gyre Therapeutics Inc Stock

₹46,225 (-46.23%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Gyre Therapeutics Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Gyre Therapeutics Inc. Average target price of $19

Gyre Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Gyre Therapeutics Inc.

What analysts predicted

60.26%UPSIDE

Target Price

$19

Current Price

$7.55

Analyzed by

6 Analysts

Target

$19.00

Gyre Therapeutics Inc target price $19, a slight upside of 60.26% compared to current price of $7.55. According to 6 analysts rating.

Gyre Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Gyre Therapeutics Inc Stock has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-20% versus previous 30 day period

Gyre Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
3
26
32
27
27
25
25
27
22
26
Gross Profit
3
25
30
25
26
24
24
26
21
25
Operating Income
0
-2
12
-91
8
3
4
0
2
2
EBITDA
0
-2
12
2
8
3
4
1
2
2
Interest Expense
0
-
-
-
-
-
-
0
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
-2
11
-100
12
6
3
0
4
2
Income Tax Expense
0
0
3
0
2
1
-1
0
0
0
Net Income
0
5
3
-52
7
3
5
0
2
0
Net Profit Margin
21.99%
21.41%
12.41%
-192.25%
27.72%
13.99%
19.63%
-0.36%
12.23%
1.65%

Gyre Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
1
0
1
0
20
1
14
113
105
Gross Profit
-4
-10
-11
-21
11
0
13
108
101
Operating Income
-13
-20
-21
-33
-57
-87
9
-67
16
EBITDA
-12
-16
-21
-33
-57
-87
10
20
17
Interest Expense
1
-
-
-
-
0
0
-
-
Depreciation
-
-
-
-
-
1
1
1
1
Income Before Tax
-14
-16
-21
-30
-56
-87
9
-76
23
Income Tax Expense
0
3
0
3
0
0
5
8
5
Net Income
-14
-16
-21
-30
-55
-13
0
-92
12
Net Profit Margin
-843.54%
-4246.87%
-2117.98%
-500916.67%
-265.14%
-1198.32%
2.25%
-81.92%
11.43%

Gyre Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-2
-1
-52
9
4
2
0
2
1
Operating Cash Flow
-2
7
3
2
-5
1
-2
0
2
Investing Cash Flow
4
1
0
-7
-8
-2
-2
1
-3
Financing Cash Flow
-3
-1
1
0
0
0
0
1
22
Change in Cash
-1
2
4
-3
-13
0
-4
3
21

Gyre Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-16
-21
-30
-55
-56
-87
2
-85
17
Operating Cash Flow
-18
-19
-28
-43
-55
-83
10
25
-3
Investing Cash Flow
-1
-11
-71
27
9
48
55
-19
-19
Financing Cash Flow
0
35
111
0
60
49
-45
2
2
Change in Cash
-18
4
11
-15
14
13
25
8
-21

Insights on Gyre Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 22.05M → 26.77M (in $), with an average increase of 17.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 114.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, GYRE stock has moved down by -6.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 2.69M → 442.0K (in $), with an average decrease of 83.6% per quarter

About Gyre Therapeutics Inc

catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.
OrganisationGyre Therapeutics Inc
Headquarters12770 High Bluff Drive, San Diego, CA, United States, 92130
CEOMr. Ping Zhang
E-voting on sharesClick here to vote

Key Management of Gyre Therapeutics Inc

Name

Title

Dr. Han Ying Ph.D.

Senior Vice President of Science

Mr. Ping Zhang

Interim CEO & Executive Chair

Mr. Songjiang Ma

President & Director

Ms. Ruoyu Chen

Chief Financial Officer

Mr. Weiguo Ye

Chief Operating Officer

FAQs

What is Gyre Therapeutics Inc share price today?

Gyre Therapeutics Inc share price today is $7.55 as on at the close of the market. Gyre Therapeutics Inc share today touched a day high of $7.85 and a low of $7.52.

What is the 52 week high and 52 week low for Gyre Therapeutics Inc share?

Gyre Therapeutics Inc share touched a 52 week high of $19 on and a 52 week low of $6.11 on . Gyre Therapeutics Inc stock price today i.e. is closed at $7.55,which is 60.26% down from its 52 week high and 23.57% up from its 52 week low.

What is Gyre Therapeutics Inc's market capitalisation today?

Gyre Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Gyre Therapeutics Inc Stock (GYRE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Gyre Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Gyre Therapeutics Inc Shares that will get you 0.1987 shares as per Gyre Therapeutics Inc share price of $7.55 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Gyre Therapeutics Inc Stock (GYRE) from India?

Indian investors can start investing in Gyre Therapeutics Inc (GYRE) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Gyre Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Gyre Therapeutics Inc share’s latest price of $7.55 as on September 18, 2025 at 1:29 am IST, you will get 1.3245 shares of Gyre Therapeutics Inc. Learn more about fractional shares .